Lactobacillus
- Generic Name
- Lactobacillus
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
主要用于消化不良以及场内异常发酵，小儿饮食不当引起的腹泻及营养不良等；也用于使用抗生素及放、化疗后引起的菌群失调性腹泻及急性肠胃炎、腹泻、痢疾等。
- Associated Conditions
- -
- Associated Therapies
- -
The Best Probiotics for IBS
Probiotics show potential in managing IBS symptoms, but evidence is mixed due to conflicting study results and small participant numbers. Specific strains like Lactobacillus acidophilus NCFM and Saccharomyces boulardii have shown promise in reducing symptoms such as abdominal pain and diarrhea. However, the effectiveness varies by individual, and more research is needed to determine the most beneficial strains for IBS.
Enrolment patterns in a randomized controlled trial of probiotics in critically ill patients
The PROSPECT trial (2015-2019) involved 2653 patients across 44 sites, testing *Lactobacillus rhamnosus GG* against placebo in ICU patients. It found no reduction in ventilator-associated pneumonia or other infections. Analysis focused on site characteristics and enrolment rates, using multivariable regression to assess predictors of recruitment.
Bladder Cancer: Optimizing Treatment Response Through the Gut Microbiome
Fecal microbiota transplant (FMT) shows promise in optimizing cancer treatment response, with Cleveland Clinic exploring its use in bladder cancer. Studies link gut microbiome changes to chemotherapy responses, suggesting FMT could enhance immunotherapy outcomes.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath